Anti-Amyloid Class Labeling Could See Changes With Lilly’s Donanemab Approval

 
• By Sue Sutter
  
Alzheimers imaging
ARIA symptoms in Alzheimer's patients may mimic the signs of ischemic stroke. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers